Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_4
1
9%
Ph not_applicable
7
64%
Ph phase_2
3
27%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
3(27.3%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
7(63.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Other(2)

Detailed Status

Completed9
unknown2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (27.3%)
Phase 41 (9.1%)
N/A7 (63.6%)

Trials by Status

completed982%
unknown218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11